^
No biomarker
Pancreatic Ductal Adenocarcinoma
SBP-101
Sensitive
:
B
No biomarker
Pancreatic Ductal Adenocarcinoma
gemcitabine
Sensitive
:
B
No biomarker
Pancreatic Ductal Adenocarcinoma
gemcitabine + capecitabine
Sensitive
:
B
BRCA2 mutation
Pancreatic Ductal Adenocarcinoma
olaparib
Sensitive
:
C1
ATM mutation
Pancreatic Ductal Adenocarcinoma
olaparib
Sensitive
:
C1
HGF-H
Pancreatic Ductal Adenocarcinoma
FOLFIRINOX
Resistant
:
C3
MSI-L/dMMR
Pancreatic Ductal Adenocarcinoma
nivolumab
Sensitive
:
C3
MSI-L/dMMR
Pancreatic Ductal Adenocarcinoma
ipilimumab
Sensitive
:
C3
MSI-L/dMMR
Pancreatic Ductal Adenocarcinoma
pembrolizumab
Sensitive
:
C3
PALB2 mutation
Pancreatic Ductal Adenocarcinoma
FOLFIRINOX
Sensitive
:
C3
BRCA1 mutation + BRCA2 mutation
Pancreatic Ductal Adenocarcinoma
FOLFIRINOX
Sensitive
:
C3
FANCF mutation
Pancreatic Ductal Adenocarcinoma
FOLFIRINOX
Sensitive
:
C3
MSH2 mutation
Pancreatic Ductal Adenocarcinoma
FOLFIRINOX
Sensitive
:
C3
BRCA2 mutation
Pancreatic Ductal Adenocarcinoma
FOLFIRINOX
Sensitive
:
C3
BRCA1 mutation
Pancreatic Ductal Adenocarcinoma
FOLFIRINOX
Sensitive
:
C3
DDR
Pancreatic Ductal Adenocarcinoma
olaparib
Sensitive
:
C3
C3M/PRO-C3 ratio elevation
Pancreatic Ductal Adenocarcinoma
PEGPH20
Sensitive
:
C3
PALB2 mutation
Pancreatic Ductal Adenocarcinoma
cisplatin + gemcitabine
Sensitive
:
C3
BRCA2 mutation
Pancreatic Ductal Adenocarcinoma
cisplatin + gemcitabine
Sensitive
:
C3
BRCA1 mutation
Pancreatic Ductal Adenocarcinoma
cisplatin + gemcitabine
Sensitive
:
C3
GATA6 underexpression
Pancreatic Ductal Adenocarcinoma
leucovorin calcium
Resistant
:
C3
GATA6 underexpression
Pancreatic Ductal Adenocarcinoma
5-fluorouracil
Resistant
:
C3
GATA6 expression
Pancreatic Ductal Adenocarcinoma
gemcitabine
Resistant
:
C3
LAMC2 overexpression
Pancreatic Ductal Adenocarcinoma
gemcitabine
Resistant
:
C3
VERI is free for non-commercial use, no login needed.
Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
For commercial access, including additional premium features, please contact us.
By using VERI, you are agreeing to our